Skip to main content
UNITED THERAPEUTICS Corp logo

UNITED THERAPEUTICS Corp — Investor Relations & Filings

Ticker · UTHR ISIN · US91307C1027 LEI · 5299005C4HZL4UWROC14 US Manufacturing
Open in API
Filings indexed 2,877 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country US United States of America
Listing US UTHR

About UNITED THERAPEUTICS Corp

https://www.unither.com/

United Therapeutics Corporation is a biotechnology company focused on the development and commercialization of therapies for chronic and life-threatening conditions. The company's primary therapeutic areas include pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). It also develops treatments for pediatric neuroblastoma. In addition to its pharmaceutical pipeline, United Therapeutics is actively engaged in research and development of technologies to manufacture transplantable organs and tissues, aiming to address the shortage of donor organs.

Recent filings

Filing Released Lang Actions
FORM SD
Regulatory Filings Classification · 91% confidence The document is a Form SD (Specialized Disclosure Report) filed under Rule 13p-1 of the Securities Exchange Act addressing conflict minerals. It is a compliance/regulatory disclosure to the SEC without financial statements or earnings data. No specific category covers Form SD conflict minerals reports, so it falls under the fallback Regulatory Filings category (RNS).
2026-06-02 English
8-K - UNITED THERAPEUTICS Corp (0001082554) (Filer)
Earnings Release Classification · 90% confidence The document is a Form 8-K current report under Item 2.02 “Results of Operations and Financial Condition,” which notifies investors that the company issued a press release announcing its quarterly earnings for the period ended March 31, 2026. This is the standard EDGAR method for filing an initial earnings release. Therefore, it should be classified as an Earnings Release (ER). Q1 2026
2026-05-06 English
10-Q - UNITED THERAPEUTICS Corp (0001082554) (Filer)
Interim / Quarterly Report Q1 2026
2026-05-06 English
ARS - UNITED THERAPEUTICS Corp (0001082554) (Filer)
Annual Report
2026-04-29 English
DEF 14A - UNITED THERAPEUTICS Corp (0001082554) (Filer)
Proxy Solicitation & Information Statement
2026-04-29 English
8-K - UNITED THERAPEUTICS Corp (0001082554) (Filer)
Regulatory Filings Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated March 30, 2026. It announces an event related to positive clinical study results and includes a press release as an exhibit. The document is 3644 characters long, which is relatively short and primarily serves as an announcement of an event rather than a detailed financial report or other specific filing. It does not contain financial statements, management discussion, or detailed data. Therefore, it fits the category of a Regulatory Filing (RNS), which is a general category for miscellaneous filings that do not fit other specific types.
2026-03-30 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.